[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Emergent Biosolutions (EBS)

Emergent Biosolutions (EBS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 249,725
  • Shares Outstanding, K 51,596
  • Annual Sales, $ 742,900 K
  • Annual Income, $ 52,600 K
  • EBIT $ 138 M
  • EBITDA $ 244 M
  • 60-Month Beta 2.35
  • Price/Sales 0.37
  • Price/Cash Flow 1.45
  • Price/Book 0.80

Options Overview Details

View History
  • Implied Volatility 92.98% (+18.13%)
  • Historical Volatility 107.96%
  • IV Percentile 69%
  • IV Rank 14.21%
  • IV High 348.73% on 03/18/26
  • IV Low 50.62% on 01/16/26
  • Expected Move (DTE 11) 0.34 (7.02%)
  • Put/Call Vol Ratio 1.50
  • Today's Volume 170
  • Volume Avg (30-Day) 201
  • Put/Call OI Ratio 0.23
  • Today's Open Interest 10,616
  • Open Int (30-Day) 10,729
  • Expected Range 4.50 to 5.18

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/26
See More
  • Average Estimate $-0.25
  • Number of Estimates 1
  • High Estimate $-0.25
  • Low Estimate $-0.25
  • Prior Year $0.71
  • Growth Rate Est. (year over year) -135.21%

Price Performance

See More
Period Period Low Period High Performance
1-Month
4.81 +0.62%
on 08/07/26
8.37 -42.17%
on 07/09/26
-3.45 (-41.62%)
since 07/07/26
3-Month
4.81 +0.62%
on 08/07/26
9.66 -49.90%
on 05/11/26
-4.29 (-46.99%)
since 05/07/26
52-Week
4.81 +0.62%
on 08/07/26
14.06 -65.58%
on 01/07/26
-3.40 (-41.26%)
since 08/07/25

Most Recent Stories

More News
Emergent Biosolutions: Q2 Earnings Snapshot

Emergent Biosolutions: Q2 Earnings Snapshot

EBS : 4.84 (-8.85%)
Emergent BioSolutions Commits to Cross-Sector Collaboration Against Biological Threats in an Evolving Global Security Environment

GAITHERSBURG, Md., Aug. 05, 2026 (GLOBE NEWSWIRE) -- Emergent BioSolutions (NYSE:EBS), a global biodefense company, today highlighted the increasing importance of biological threat preparedness as allied...

EBS : 4.84 (-8.85%)
Emergent BioSolutions Reports Second Quarter 2026 Financial Results

Second Quarter 2026 Total Revenues of $234.3 million, an improvement of 66% versus prior year Second Quarter 2026 Net Loss of $180.2 million worsening 1,402% versus prior year, largely due to a $191.3...

EBS : 4.84 (-8.85%)
Emergent BioSolutions to Report Second Quarter 2026 Financial Results on August 5, 2026

GAITHERSBURG, Md., July 22, 2026 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) will host a conference call on Wednesday, August 5, 2026, at 5:00 p.m. eastern time to discuss the financial...

EBS : 4.84 (-8.85%)
Emergent BioSolutions Secures Contract Modification Valued at Approximately $52.7 Million for ACAM2000® (Smallpox and Mpox (Vaccinia) Vaccine, Live) from the U.S. Government

GAITHERSBURG, Md., June 29, 2026 (GLOBE NEWSWIRE) -- Emergent BioSolutions (NYSE:EBS) today announced it has been awarded a contract modification valued at $52.7 million from the Administration for Strategic...

EBS : 4.84 (-8.85%)
Emergent BioSolutions Supports Victoria’s Voice Foundation’s National Naloxone Awareness Day to Help Save Lives from Opioid Overdose

GAITHERSBURG, Md., June 04, 2026 (GLOBE NEWSWIRE) -- In honor of National Naloxone Awareness Day on June 6 th , Emergent BioSolutions Inc. (NYSE: EBS) is teaming up with Victoria’s Voice Foundation...

EBS : 4.84 (-8.85%)
Emergent BioSolutions Receives $64.5 Million Contract Modification for BAT® [Botulism Antitoxin Heptavalent (A, B, C, D, E, F, G) – (Equine)] to Support U.S. Biodefense Strategy

GAITHERSBURG, Md., May 28, 2026 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today announced it has been awarded a contract modification valued at approximately $64.5 million from the Administration...

EBS : 4.84 (-8.85%)
Emergent BioSolutions to Participate in Upcoming Investor Conferences

GAITHERSBURG, Md., May 20, 2026 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) announced today that members of the company’s senior management team will participate in the following investor...

EBS : 4.84 (-8.85%)
Emergent BioSolutions Receives Saudi Food and Drug Authority Approval for ACAM2000® [Smallpox and Mpox (Vaccinia) Vaccine, Live]

GAITHERSBURG, Md., May 18, 2026 (GLOBE NEWSWIRE) -- Emergent BioSolutions (NYSE:EBS), a global biodefense company, today announced that the Saudi Food and Drug Authority (SFDA) has approved the registration...

EBS : 4.84 (-8.85%)
Emergent Biosolutions: Q1 Earnings Snapshot

Emergent Biosolutions: Q1 Earnings Snapshot

EBS : 4.84 (-8.85%)

Business Summary

Emergent BioSolutions, Inc. is a global specialty biopharmaceutical company offering specialized products to health care providers and governments to combat emerging public health threats. It also supplies vaccines to domestic and international non-government organizations and governments in/ outside...

See More

Key Turning Points

3rd Resistance Point 6.06
2nd Resistance Point 5.81
1st Resistance Point 5.32
Last Price 4.84
1st Support Level 4.58
2nd Support Level 4.33
3rd Support Level 3.84

See More

52-Week High 14.06
Fibonacci 61.8% 10.53
Fibonacci 50% 9.44
Fibonacci 38.2% 8.34
Last Price 4.84
52-Week Low 4.81

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.